(S (NP (NP (DT The) (NN research)) (VP (VBN reported) (PP (IN in) (NP (DT this) (NN paper))))) (VP (VBZ identifies) (NP (NP (DT the) (JJ epigenetic) (NN biomarker) (PRN (-LRB- -LRB-) (NP (NN methylation) (NML (NN beta) (NN pattern))) (-RRB- -RRB-))) (PP (IN of) (NP (NN breast) (NN cancer))))) (. .))
(S (NP (JJ Many) (NNS cancers)) (VP (VBP are) (VP (VBN triggered) (PP (IN by) (NP (NP (JJ abnormal) (NN gene) (NN expression) (NNS levels)) (VP (VBN caused) (PP (IN by) (NP (NP (JJ aberrant) (NN methylation)) (PP (IN of) (NP (NN CpG) (NNS sites))))) (PP (IN in) (NP (DT the) (NN DNA)))))))) (. .))
(S (PP (IN In) (NP (NN order) (S (VP (VP (TO to) (VP (VB develop) (NP (NP (JJ early) (NNS diagnostics)) (PP (IN of) (NP (ADJP (NN cancer) (HYPH -) (VBG causing)) (NNS methylations)))))) (CC and) (VP (TO to) (VP (VB develop) (NP (DT a) (NN treatment)))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB identify) (NP (QP (DT a) (JJ few) (NN dozen)) (JJ key) (NML (ADJP (NN cancer) (HYPH -) (VBN related)) (NN CpG)) (NN methylation) (NNS sites)) (PP (IN out) (PP (IN of) (NP (NP (DT the) (NNS millions)) (PP (IN of) (NP (NP (NNS locations)) (PP (IN in) (NP (DT the) (NN DNA))))))))))))) (. .))
(NP (NP (DT This) (NN research)) (VP (VBN used) (NP (JJ public) (NN TCGA) (NN dataset)) (S (VP (TO to) (VP (VB train) (NP (DT a) (NNP TensorFlow) (NML (NN machine) (NN learning)) (NN model)) (S (VP (TO to) (VP (VB classify) (NP (NP (NN breast) (NN cancer)) (CC versus) (NP (JJ non-breast-cancer) (NN tissue) (NNS samples))))))))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (QP (IN over) (CD 300,000)) (NML (NN methylation) (NN beta)) (NNS values)) (PP (IN in) (NP (DT each) (NN sample))))))) (. .))
(S (NP (NN L1) (NN regularization)) (VP (VBD was) (VP (VBN applied) (S (VP (TO to) (VP (VB identify) (NP (NP (DT the) (NML (NN CpG) (NN methylation)) (NNS sites)) (ADJP (RBS most) (JJ important))) (PP (IN for) (NP (JJ accurate) (NN classification)))))))) (. .))
(S (NP (PRP It)) (VP (VBD was) (VP (VBN hypothesized) (SBAR (IN that) (S (NP (NP (NN CpG) (NNS sites)) (PP (IN with) (NP (NP (DT the) (JJS highest)) (VP (VBN learned) (NP (NN model) (NNS weights)))))) (VP (VBP correspond) (PP (IN to) (NP (NP (NN DNA) (NNS locations)) (ADJP (RBS most) (JJ relevant)))) (PP (IN to) (NP (NN breast) (NN cancer)))))))) (. .))
(S (NP (NP (DT A) (VBN reduced) (NN model)) (VP (VBN trained) (PP (IN on) (NP (NP (NN methylation) (NNS betas)) (PP (IN of) (S (NP (RB just) (DT the) (NML (CD 25) (NN CpG)) (NNS sites)) (VP (VBG having) (NP (NP (DT the) (JJS highest) (NNS weights)) (PP (IN in) (NP (NP (DT the) (JJ full) (NN model)) (-LRB- -LRB-) (VP (VBN trained) (PP (IN on) (NP (NN methylation) (NNS betas))) (PP (IN at) (PP (IN over) (NP (NML (CD 300,000) (NN CpG)) (NNS sites))))) (-RRB- -RRB-))))))))))) (VP (VBZ has) (VP (VBN achieved) (PP (IN over) (NP (NML (CD 94) (NN %)) (NN accuracy))) (PP (IN on) (NP (NN evaluation) (NNS data))) (, ,) (S (VP (VBG confirming) (SBAR (IN that) (S (NP (DT the) (VBN identified) (NML (CD 25) (NN CpG)) (NNS sites)) (VP (VBP are) (ADVP (RB indeed)) (NP (NP (DT a) (NN biomarker)) (PP (IN of) (NP (NN breast) (NN cancer))))))))))) (. .))
